Antibodies and gene therapy: teaching old ‘magic bullets’ new tricks
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 25 (2) , 85-91
- https://doi.org/10.1016/j.it.2003.12.001
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapyGene Therapy, 2003
- Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptorOncogene, 2003
- HighIn VivoProduction of a Model Monoclonal Antibody on Adenoviral Gene TransferHuman Gene Therapy, 2002
- Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matricesGene Therapy, 2002
- Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic proteinJournal of Molecular Biology, 2002
- The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodiesJournal of Molecular Biology, 2002
- Novel tetravalent and bispecific IgG‐like antibody molecules combining single‐chain diabodies with the immunoglobulin γ1 Fc or CH3 regionFEBS Letters, 1999
- In VitroandIn VivoSecretion of Cloned Antibodies by Genetically Modified Myogenic CellsHuman Gene Therapy, 1997
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6-specific SCFV: ζ-chimeraInternational Journal of Cancer, 1996